If any scientist ihas developed a Immortal heterohybridoma line secreting monoclonal anti-D antibodies, we are keen to collaborate to take the research to clinical level for conducting the preclinical and clinical studies. If the project succeed, will share the sales profit cost with the scientist, which can be worked out. Anticipating for the research project to take it to next level.